Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

RA-PRO PRAGMATIC TRIAL

ClinicalTrials.gov ID: NCT04692493

Public ClinicalTrials.gov record NCT04692493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients With Rheumatoid Arthritis: The RA-PRO Pragmatic Trial (RA-PROPR)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (tsDMARD; choose among existing medications, currently, tofacitinib, baricitinib, upadacitinib) in patients with active RA despite the use of a TNFi-biologic. In practice, most patients receive another TNFi-biologic, i.e., a second TNFi-biologic first. This is not based on solid evidence, but on arbitrary algorithms often proposed by health insurance plans, and/or physician experience and habit (TNFis launched 22 yrs ago vs. the first tsDMARD 8 years ago vs. first non-TNF-biologic launched 17 years ago). This study will fill a critical knowledge gap by generating CER data for important PROs between these treatment options, switching to a non-TNFi biologic or a tsDMARD in patients with active RA despite the use of a TNFi-biologic.

Study identification

NCT ID
NCT04692493
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
924 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2021
Primary completion
May 30, 2029
Completion
Jul 30, 2029
Last update posted
Jul 16, 2026

2021 – 2029

United States locations

U.S. sites
48
U.S. states
18
U.S. cities
44
Facility City State ZIP Site status
East Alabama Arthritis Center PC Auburn Alabama 36830 Recruiting
Bendcare, LLC Birmingham Alabama 35244 Recruiting
University of Alabama at Birmingham Birmingham Alabama 35294 Recruiting
SunValley Arthritis Center, Ltd Peoria Arizona 85381 Recruiting
University of Arizona Tucson Arizona 85724 Recruiting
Pacific Arthritis Care Center Los Angeles California 90045 Recruiting
University of California, Los Angeles Los Angeles California 90095 Recruiting
Arthritis Medical Center Nipomo California 93444 Recruiting
Turlock Arthritis & Osteoporosis Center, Turlock California 95382 Recruiting
Center for Rheumatology Research Woodland Hills California 91364 Recruiting
George Munoz MD, PC Aventura Florida 33180 Recruiting
American Arthritis and Rheumatology Associates LLC Clearwater Florida 33765 Recruiting
CZ Rheumatology Coral Springs Florida 33065 Recruiting
American Arthritis and Rheumatology Associates LLC Fort Lauderdale Florida 33309 Recruiting
Mayo Clinic Jacksonville Jacksonville Florida 32224 Recruiting
Palm Beach Rheumatology and Wellness Jupiter Florida 33458 Recruiting
Arthritis & Rheumatology Center of South Florida Margate Florida 33063 Recruiting
Life Medical Research Group Miami Gardens Florida 33014 Recruiting
Southwest Florida Rheumatology Riverview Florida 33569 Recruiting
Southeast Georgia Physician Associates-Rheumatology Brunswick Georgia 31520 Recruiting
Indiana University Health Carmel Indiana 46280 Recruiting
Johns Hopkins University Baltimore Maryland 21224 Recruiting
Tufts University Boston Massachusetts 02111 Recruiting
University of Massachusetts Chan Medical School Worcester Massachusetts 01655 Recruiting
American Arthritis and Rheumatology Associates -Mi PLLC Okemos Michigan 48864 Recruiting
Saint Paul Rheumatology, P.A. Eagan Minnesota 55121 Recruiting
Mayo Clinic Rochester Rochester Minnesota 55905 Recruiting
Dr. Jayashree Sinha Clovis New Mexico 88101 Recruiting
Inspire Santa Fe Medical Group Santa Fe New Mexico 87505 Recruiting
New York University New York New York 10016 Recruiting
Hospital for Special Surgery New York New York 10021 Recruiting
University Hospital Cleveland Medical Ctr Cleveland Ohio 44106 Recruiting
The MetroHealth System Cleveland Ohio 44109 Recruiting
Arthritis and Rheumatology of Southwest Ohio Liberty Township Ohio 45069 Recruiting
Southern Ohio Rheumatology Wheelersburg Ohio 45694 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 Recruiting
Rheumatology and Arthritis Care Center Exton Pennsylvania 19341-2547 Recruiting
Allegheny Health Network Pittsburgh Pennsylvania 15212 Recruiting
PA Regional Center for Arthritis and Osteoporosis Research Wyomissing Pennsylvania 19610 Recruiting
Cumberland Rhematology Crossville Tennessee 38555 Recruiting
Vanderbilt University Nashville Tennessee 37235 Recruiting
Heritage Rheumatology and Arthritis Care Colleyville Texas 76034 Recruiting
Southwest Medical Center Dallas Texas 75235 Recruiting
Texas Arthritis Center, PA El Paso Texas 77902 Recruiting
American Arthritis and Rheumatology Associates-Tx PLLC Harlingen Texas 78550 Recruiting
Baylor University Houston Texas 77030 Recruiting
Northern Virginia Center for Arthritis-Reston Reston Virginia 20190 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04692493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04692493 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →